当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 利润表

博雅生物

(300294)

  

流通市值:63.99亿  总市值:63.99亿
流通股本:5.04亿   总股本:5.04亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入846,914,941.7643,555,888.03321,128,375.862,059,088,027.17
  营业收入846,914,941.7643,555,888.03321,128,375.862,059,088,027.17
二、营业总成本836,500,603.21614,673,835.61296,220,781.811,738,837,657.08
  营业成本482,972,407.13359,063,537.9172,563,810.331,031,721,835.18
  税金及附加12,751,310.2610,002,055.495,071,317.5719,374,755.99
  销售费用198,643,315.42148,184,047.0873,703,551.86412,671,829.14
  管理费用147,491,844.37103,289,144.6650,714,378.77239,178,310.56
  研发费用18,178,029.8711,990,387.434,235,819.0954,554,236.59
  财务费用-23,536,303.84-17,855,336.95-10,068,095.81-18,663,310.38
  其中:利息费用1,875,623.891,247,412.3631,044.981,161,725.54
  其中:利息收入11,768,964.188,339,954.64,073,006.4113,615,107.1
三、其他经营收益
  加:公允价值变动收益20,785,470.4710,444,438.136,725,948.9759,977,597.95
  加:投资收益-32,105,155.72-34,436,670.693,933,274.523,806,314.16
  资产处置收益-528,699.72-394,883.47-348,365.675,095,324.42
  资产减值损失(新)-160,000.57-156,560.68-155,939.71-316,529,570.79
  信用减值损失(新)5,818,381.56-4,720,502.68-1,582,061.29-23,652,590.17
  其他收益7,574,952.465,842,568.13,667,173.7440,474,982.72
四、营业利润11,799,286.975,460,441.1337,147,624.59109,422,428.38
  加:营业外收入716,877683,778.51143,120.153,023,017.98
  减:营业外支出11,715,310.742,718,184.211,287,236.198,566,951.28
五、利润总额800,853.233,426,035.4336,003,508.55103,878,495.08
  减:所得税费用-59,787,411.6-47,458,848.15,970,116.3-8,760,276.94
六、净利润60,588,264.8350,884,883.5330,033,392.25112,638,772.02
(一)按经营持续性分类
  持续经营净利润33,692,910.1323,989,528.8330,033,392.25112,638,772.02
  终止经营净利润26,895,354.726,895,354.7--
(二)按所有权归属分类
  归属于母公司股东的净利润62,337,285.7251,188,692.0830,220,896.06112,698,348.56
  少数股东损益-1,749,020.89-303,808.55-187,503.81-59,576.54
  扣除非经常损益后的净利润30,136,840.5517,151,386.5120,323,474.32-7,757,477.26
七、每股收益
  (一)基本每股收益0.120.10.060.22
  (二)稀释每股收益0.120.10.060.22
八、其他综合收益-13,172,038.35-10,184,885.93-5,943,787.21-5,885,761.41
  归属于母公司股东的其他综合收益-13,172,038.35-10,184,885.93-5,943,787.21-5,885,761.41
九、综合收益总额47,416,226.4840,699,997.624,089,605.04106,753,010.61
  归属于母公司股东的综合收益总额49,165,247.3741,003,806.1524,277,108.85106,812,587.15
  归属于少数股东的综合收益总额-1,749,020.89-303,808.55-187,503.81-59,576.54
公告日期2026-10-302026-08-222026-04-252026-03-21
审计意见(境内)标准无保留意见
TOP↑